KoBioLabs

KoBioLabs, Inc. is a biotechnology company based in Seoul, South Korea, specializing in microbiome therapeutics. The company focuses on developing innovative treatments for a range of health conditions, including metabolic, immune, and neurological diseases. Through its research efforts, KoBioLabs aims to harness the potential of the microbiome to create effective medicinal solutions that address these critical areas of human health.

Top Sectors

Healthcare Biotechnology Therapeutics Life Science

Top Regions

South Korea Eastern Asia Asia

http://kobiolabs.com

https://crunchbase.com/organization/kobiolabs

https://facebook.com/kobiolabs

https://linkedin.com/company/kobiolabs

https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=596275317

GwangPyo Ko

Founder / CEO

1 past transactions

WeBiom

Venture Round in 2022

Webiome is a company focused on developing probiotic-based health supplements that leverage microbiome technology. Specializing in microbiome lactobacilli, Webiome aims to provide products that promote inner beauty and overall well-being. By utilizing this innovative approach, the company seeks to enhance consumers' health and help them maintain a healthy lifestyle.

Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.